Latest Ischemia Stories
Patents granted for innovative minimally invasive technology for Acute Ischemic Stroke treatment, strengthening Neuravi's patent portfolio. Galway, Ireland
Experienced in European and Global Medical Technology Launches NEW YORK, Sept 23, 2014 /PRNewswire/ -- Vesselon, Inc.
Placement Agent Spencer Trask Ventures Rallies investors to "Take Stock in Stroke" NEW YORK, Aug. 4, 2014 /PRNewswire/ -- Vesselon, Inc.
Previous studies have indicated that electrical stimulation of the cerebellar fastigial nucleus in rats may reduce brain infarct size, increase the expression of Ku70 in cerebral ischemia/reperfusion region, and decrease the number of apoptotic neurons.
Nearly two million Americans a year suffer from ischemia reperfusion injuries. A wide variety of scenarios can be caused by these injuries that result in blood flow—from traumatic limb injuries, to heart attacks, to donor organs.
Dl-3n-butylphthalide can effectively treat cerebral ischemia; however, the mechanisms underlying the effects of dl-3n-butylphthalide on microcirculation disorders following diffuse brain injury remain unclear.
New research has shown human neural stem cells could improve blood flow in critical limb ischemia through the growth of new vessels.
Interestingly, a recent study found that ischemic stress causes hyperglycemia and may worsen ischemic neuronal damage.
Ischemic stroke is characterized by an interruption of the blood supply to the brain, which can lead to brain damage and even death.
- The act of burning, scorching, or heating to dryness; the state or being thus heated or dried.
- In medicine, cauterization.